Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BICYCLE THERAPEUTICS plc | CHIEF DEVELOPMENT OFFICER | Ordinary Shares | 39K | $683K | $17.50 | Feb 6, 2024 | Direct |
MARINUS PHARMACEUTICALS INC | Director | Common Stock | 2.75K | $24.6K | $8.93 | Feb 4, 2022 | Direct |
Fulcrum Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 400K | Nov 7, 2022 | Direct | ||
BICYCLE THERAPEUTICS plc | CHIEF DEVELOPMENT OFFICER | Employee Stock Option (right to buy) | 41.6K | Feb 6, 2024 | Direct | ||
MARINUS PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 12.4K | Feb 4, 2022 | Direct | ||
Fulcrum Therapeutics, Inc. | Chief Medical Officer | No securities are beneficially owned | 0 | Nov 7, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BCYC | BICYCLE THERAPEUTICS plc | Feb 6, 2024 | 2 | $0 | 4 | Feb 8, 2024 | CHIEF DEVELOPMENT OFFICER |
BCYC | BICYCLE THERAPEUTICS plc | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Chief Development Officer |
BCYC | BICYCLE THERAPEUTICS plc | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Chief Development Officer |
BCYC | BICYCLE THERAPEUTICS plc | Mar 31, 2023 | 0 | $0 | 3 | Apr 4, 2023 | Chief Development Officer |
FULC | Fulcrum Therapeutics, Inc. | Nov 7, 2022 | 1 | $0 | 4 | Nov 9, 2022 | Chief Medical Officer |
FULC | Fulcrum Therapeutics, Inc. | Nov 7, 2022 | 0 | $0 | 3 | Nov 9, 2022 | Chief Medical Officer |
MRNS | MARINUS PHARMACEUTICALS INC | Feb 4, 2022 | 2 | $0 | 4 | Feb 7, 2022 | Director |
MRNS | MARINUS PHARMACEUTICALS INC | Jul 1, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
MRNS | MARINUS PHARMACEUTICALS INC | Jul 1, 2021 | 0 | $0 | 3 | Jul 1, 2021 | Director |